# SMARCA5 is required for the development of granule cell neuron precursors and Sonic Hedgehog Medulloblastoma growth

**Authors:** Foteini Tsiami, Layla Drwesh, Surender Surender, Julia Fitzgerald, Jens Schittenhelm, David J. Picketts, Rosalind A. Segal, Ghazaleh Tabatabai, Daniel J. Merk

PMC · DOI: 10.1038/s41598-025-11857-3 · 2025-07-18

## TL;DR

This study shows that the SMARCA5 gene is essential for the development of certain brain cells and for the growth of a specific type of brain tumor called Sonic Hedgehog Medulloblastoma.

## Contribution

The study identifies SMARCA5 as a novel genetic dependency in Sonic Hedgehog Medulloblastoma using CRISPR-Cas9 screening and mouse models.

## Key findings

- SMARCA5 knockout inhibits SHH pathway activation and tumor cell proliferation in SHH-MB.
- Conditional deletion of SMARCA5 in granule cell neuron precursors reduces their proliferative capacity and causes cerebellar hypoplasia.
- Loss of SMARCA5 in a mouse model of SHH-MB leads to prolonged survival of tumor-bearing mice.

## Abstract

Medulloblastoma constitutes a molecularly diverse group of malignant embryonal brain tumors. Sonic hedgehog molecular group of medulloblastoma (SHH-MB) is a highly heterogeneous tumor entity, characterized by constitutive activation of the SHH signaling pathway. Due to lack of suitable cell line models, little is known about genetic dependencies in SHH-MB outside of the SHH pathway. By performing a CRISPR-Cas9 dropout screen in SMB21 cells derived from SHH-MB in Ptch+/− mice, we aimed to identify genetic vulnerabilities in SHH-MB. Among the top scored gene hits, members of the SNF2-family of ATP-dependent chromatin remodelers including Smarca5 emerged as genetic dependencies in SHH-MB, and we validate that Smarca5 knockout inhibits SHH pathway activation and SHH-MB cell proliferation. Additional genetic ablation experiments in vivo revealed that conditional deletion of Smarca5 in cerebellar granule cell neuron precursors (GCNPs), the cell origin of SHH-MB, significantly reduces the proliferative capacity of GCNPs and leads to cerebellar hypoplasia in mice. Furthermore, loss of Smarca5 in GCNPs in an established mouse model of SHH-MB results in prolonged survival of tumor bearing mice. Our data underline the critical role of SMARCA5 during the development of the cerebellum and the pathogenesis of SHH-MB.

The online version contains supplementary material available at 10.1038/s41598-025-11857-3.

## Linked entities

- **Genes:** SMARCA5 (SNF2 related chromatin remodeling ATPase 5) [NCBI Gene 8467], PTCH1 (patched 1) [NCBI Gene 5727]
- **Diseases:** Medulloblastoma (MONDO:0002794)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Ptch1 (patched 1) [NCBI Gene 19206] {aka A230106A15Rik, Ptc, Ptc1, Ptch, mes, wig}, Smarca5 (SNF2 related chromatin remodeling ATPase 5) [NCBI Gene 93762] {aka 4933427E24Rik, D030040M08Rik, D330027N15Rik, MommeD4, Snf2h}, Shh (sonic hedgehog) [NCBI Gene 20423] {aka 9530036O11Rik, Dsh, HHG-1, Hhg1, Hx, Hxl3}
- **Diseases:** SHH-MB (OMIM:613675), embryonal brain tumors (MESH:D001932), tumor (MESH:D009369), cerebellar hypoplasia (MESH:C562568), Medulloblastoma (MESH:D008527)
- **Chemicals:** ATP (MESH:D000255)
- **Species:** Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** SHH-MB — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_IQ83), SMB21 — Homo sapiens (Human), Peripheral primitive neuroectodermal tumor of bone, Cancer cell line (CVCL_S863)

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12274346/full.md

---
Source: https://tomesphere.com/paper/PMC12274346